Skip to main content

Oral and Dental Conditions News (Page 3)

Related terms: Dental

FDA Medwatch Alert: Oral Over-the-Counter Benzocaine Products: Drug Safety Communication - Risk of Serious and Potentially Fatal Blood Disorder

ISSUE: The FDA is warning that over-the-counter (OTC) oral drug products containing benzocaine should not be used to treat infants and children younger than 2 years. We are also warning that...

FDA Medwatch Alert: Certain Homeopathic Teething Products: FDA Warning- Confirmed Elevated Levels of Belladonna

ISSUE: FDA announced that its laboratory analysis found inconsistent amounts of belladonna, a toxic substance, in certain homeopathic teething tablets, sometimes far exceeding the amount claimed on...

FDA Medwatch Alert: Products Containing Belladonna Extract by Raritan Pharmaceuticals: Recall - Possible Belladonna Alkaloids

[Posted 11/25/2016] ISSUE: Raritan Pharmaceuticals, a contract manufacturer for Homeolab USA, is voluntarily recalling homeopathic products containing belladonna extract (see products below) due to...

FDA Medwatch Alert: Homeopathic Teething Tablets and Gels: FDA Warning - Risk to Infants and Children

ISSUE: The FDA is warning consumers that homeopathic teething tablets and gels may pose a risk to infants and children. The FDA is analyzing adverse events reported to the agency regarding...

FDA Medwatch Alert: Lidocaine Viscous: Drug Safety Communication - Boxed Warning Required - Should Not Be Used to Treat Teething Pain

ISSUE: FDA notified health professionals, their provider organizations and caregivers for infants, that prescription oral viscous lidocaine 2% solution should not be used to treat infants and...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Dental Abscess, Xerostomia, Toothache, Burning Mouth Syndrome, Aphthous Ulcer

Related drug support groups

Orajel